Ivermectin as a potential treatment for COVID-19?
Author:
Publisher
Public Library of Science (PLoS)
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health
Reference16 articles.
1. Dexamethasone in hospitalized patients with Covid-19;RECOVERY Collaborative Group;N Engl J Med,2021
2. Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: A propensity score-matched analysis;ML Meizlish;Am J Hematol,2021
3. Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine;M Levine-Tiefenbrun;Nat Med,2021
4. Interventions for treatment of COVID-19: Second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project);S Juul;PLoS One,2021
5. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro;L Caly;Antiviral Res,2020
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Introductory Chapter: Current Perspective of COVID-19 Drugs;COVID-19 Drug Development - Recent Advances, New Perspectives and Applications;2022-12-07
2. SARS CoV-2 Seroprevalence in Selected States of High and Low Disease Burden in Nigeria;JAMA Network Open;2022-10-11
3. The use of Ivermectin for the treatment of COVID-19: Panacea or enigma?;Clinical Epidemiology and Global Health;2022-07
4. Ivermectin Poisoning with Neurological Manifestations in 10 Years Old Girl – A Case Report;Journal of Gandhara Medical and Dental Science;2022-07-01
5. Could the COVID-19-Driven Increased Use of Ivermectin Lead to Incidents of Imbalanced Gut Microbiota and Dysbiosis?;Probiotics and Antimicrobial Proteins;2022-02-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3